Dr. Peter Black receives the 2018 MSFHR Health Professional-Investigator Award
Dr. Peter Black received the award for the project title of Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer.
CIHR Research Projects Funded
Vancouver Prostate Centre investigators were highly successful, receiving 6 Canadian Institutes of Health Research (CIHR) research grants in the Fall 2017 Project Grants competition ( http://www.cihr-irsc.gc.ca/e/50802.html ) for a total of $3.48 million over five years.
The projects funded are listed below.
Ralph Buttyan (co-Is: Artem Cherkasov, Nathan Lack, Na Li): 3 years, $344,250
Interference with Gli to Control Castration Resistant Prostate Cancer
Artem Cherkasov (co-Is: Paul Rennie): 3 years, $459,000
Design and evaluation of small molecules that target the dimerization interface of full-length and splice-variant forms of the androgen receptor as a potential treatment for advanced prostate cancer
Mads Daugaard & William Derry (Hospital for Sick Children, Toronto): 5 years, $1,113,075
Role of alternative polyadenylation in Ras-driven cancers
Xuesen Dong: 5 years, $699,975
RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors
Martin Gleave & Nathan Lack (co-Is: Artem Cherkasov, Paul Rennie, Robert Young) – Commercialization Project Grant: 2 years, $351,900
Preclinical development of a novel androgen receptor antagonist to treat castration-resistant prostate cancer
Alex Wyatt & Kim Chi: 3 years, $516,375
Predicting therapy resistance in castration-resistant prostate cancer with circulating tumor DNA
Dr. Martin Gleave is named Member of the Order of Canada
Created in 1967, the Order of Canada, one of our country’s highest civilian honours, recognizes outstanding achievement, dedication to the community and service to the nation. Dr. Gleave was appointed on December 29th for his research on the mechanisms involved in the propagation of cancer cells and for his leadership in the development of new treatments for prostate cancer.
Dr. Elspeth McDougall receives the 2017 Karl Storz Lifetime Achievement Award
Dr. McDougall is the first woman member of the Endourological Society, having joined the society in 1988, and also the first woman to be awarded this prestigious honour. The annual award is given to a senior endourologist whose lifetime contributions have had a major impact on the field of Endourology.
Dr. Ben Chew receives the 2017 Industry Award for Innovations in Endourological Instrumentation
This award is presented by the Endourological Society to individuals in industry and the company they represent who have promoted Endourology worldwide through product development, support of the society’s foreign fellows program, aided the international distribution of the Journal of Endourology, and/or provided grants in aid for the annual World Congress meeting.
Dr. Christopher Ong receives the 2017 MSFHR Innovation to Commercialization Award
In the first Innovation to Commercialization Competition, Dr. Christopher Ong received the award for the project title of Development of A Novel Biotherapeutic Fusion Protein Inhibitor For Treatment of Advanced Prostate Cancer.
Dr. Caigon Du receives the 2017 MSFHR Innovation to Commercialization Award
In the first Innovation to Commercialization Competition, Dr. Caigon Du received the award for the project title of Development of A Novel Organ Preservation Solution in Transplantation.
Dr. Lynn Stothers is a Primary Recipient of a Wall Scholar Award from the Peter Wall Institute for Advanced Studies
During her time as a Wall Scholar, Dr. Stothers will investigate the ‘mind-body-bladder’ connection in health and disease using novel technology.
Dr. Martin Gleave receives the Urology Care Foundation 2017 Richard D. Williams, MD Prostate Cancer Research Excellence Award
Since 2013, the Urology Care Foundation has presented the Williams Award, named in honor of the late urologist, scientist, mentor, and humanitarian. The Williams Award is presented annually to an individual (e.g. urologist, scientist, or researcher) for outstanding and impactful research and work in the field of prostate cancer.